Interview with Ziggy, page-25

First 25 Last

Share
Profile

Follow
futurenow

4,197 Posts.

228

16/06/16

15:54

Post #: 18049069
Share

Originally posted by BrianJohnson ↑

So much wrong with this, sigh - why do you persist with this campaign of misinformation?

Lets review what actually was said.

1. When LWP were developing the HSP, Ziggy said that he would be happy to take $0.04 before the test results were released on it, and $0.10 after they were. This was so long ago it isn't relevant...like you and your comments.

2. The current comment today about the share price being worth $.25 is based on the LSP and Battery tech doing well, and obtaining revenue deals. Unlike you, i've got a better understanding of the economics of this, and I can tell you this is actually a conservative estimate. Stop spreading fear so you can buy in lower.

3. The LSP licensing deals are based around geographic regions, plant size and the amount produced. The $2.5M is a flat fee to set it up, plus the royalties. A single customer is likely to give about $25M a year in revenue to LWP. How do it know this? By understanding the market, talking to companies (including LWP) and doing the hard work building networks.

4. The Battery tech is beyond amazing and in my own opinion could deliver a far larger market cap then the LSP, although it will come later.

5. The comments today about the LSP revenue deals are 3-6 months. This doesn't mean the deals wont be signed long before this.

Seriously, grow up.

Expand

1. Why isn't it relevant?
2. The battery tech is still a patent. Do you expect customers to pay millions for a prototype?
3. At $25M/customer. LWP will need ~30 customers to reach 25c or $800M MC in 12 months.
4. Quantum Leap. Holy Grail. Groundbreaking and now Beyond Amazing.
5. Didn't the StimLab results take close to 3 months on the HSP? Results are still pending.

LWP Price at posting: 0.6¢ Sentiment: Sell Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 111 more messages in this thread...

First 25 Last

Add TIH (ASX) to my watchlist

Interview with Ziggy, page-25

Top Stories

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACCC seeks Olam divestments before it can buy Namoi Cotton

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News